|
IFAT
|
ELISA
|
WB
|
---|
|
Median
|
CI
|
Median
|
CI
|
Median
|
CI
|
Non-endemic area: sample prevalence 0.02% (CI: 0.00–0.16)
|
Sensitivity
|
0.33
|
0.01–0.96
|
0.38
|
0.02–0.97
|
0.41
|
0.02–0.96
|
Specificity
|
0.99
|
0.94–1.00
|
0.98
|
0.92–1.00
|
0.96
|
0.90–0.99
|
Endemic area: sample prevalence 0.10% (CI: 0.01–0.96)
|
Sensitivity
|
0.43
|
0.07–0.93
|
0.26
|
0.00–0.94
|
0.64
|
0.07–0.99
|
Specificity
|
0.84
|
0.18–0.95
|
0.98
|
0.30–1.00
|
0.84
|
0.06–0.96
|
Affected by leishmaniosis: sample prevalence 0.89% (CI: 0.01–1.00)
|
Sensitivity
|
0.89
|
0.08–0.99
|
0.94
|
0.13–1.00
|
0.94
|
0.09–1.00
|
Specificity
|
0.21
|
0.01–0.95
|
0.18
|
0.00–0.93
|
0.16
|
0.00–0.94
|
-
Abbreviation: CI 0.95 credible interval